InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
+22.5%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by M. Schaeffer, Director. Director active across 1 company, notably Vivoryon Therapeutics N.V.. Aggregated, 9 disclosures have been published. History available since 30 November 2020. The latest transaction was filed on 17 April 2026 (Purchase). Regulator: AFM. All data is free.
Declarations9 total
150,000 shares0OptieAFM:192625
Ideal exit: 12 Jan 2027 (T+270)
75,000 shares0OptieAFM:171766
Ideal exit: 10 Dec 2025 (T+270)
120,000 shares0OptieAFM:159529
Ideal exit: 3 Mar 2025 (T+270)
-3,867 shares@ €2.00100.0% of flowGewoon aandeelAFM:155125
90,000 shares0OptieAFM:152998
Ideal exit: 6 Oct 2024 (T+270)
40,000 shares0OptieAFM:144118
Ideal exit: 5 Sept 2023 (T+270)
150,000 shares0OptieAFM:144117
Ideal exit: 20 Jan 2023 (T+270)
236,775 shares0OptieAFM:144116
Ideal exit: 31 Aug 2021 (T+270)
3,867 shares0Gewoon aandeelAFM:104867
Ideal exit: 27 Aug 2021 (T+270)
9 of 9 declarations
About M. Schaeffer
M. Schaeffer is a board member of Vivoryon Therapeutics N.V., a company specializing in the development of therapeutic treatments. He contributes to the strategic direction of the company and oversees its operations. His expertise in the biopharmaceutical field is an asset for Vivoryon.
